Coloplast lowers its guidance again
Denmark’s Coloplast has lowered its full year guidance for the second time this fiscal year in what an analyst calls a surprising turn of events. The share price takes the biggest plunge in seven years.
BY ANTON GRÆSDAL MAAJEN & TINA KRARUP
The Danish-based medtech group Coloplast has lowered its guidance for the fiscal year 2014/2015. The company says in a press release that the lowering is a result of continued challenges in its UK homecare business, Charter, as well as lower campaign activity in the US chronic care business.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Void contract could lead to Coloplast acquisition
For abonnenter
Coloplast cancels commercial partnership
For abonnenter
Analysis: New Coloplast strategy could boost profit
For abonnenter
